Construction is underway on the new Morrissey Boulevard headquarters of fitness wear company Nobull inside the former home of the Boston Globe.
Nobull is among the first tenants to occupy space in the redeveloped building, which housed the Globe’s newsroom and printing presses before it moved downtown in 2017.
Nobull, which currently has offices by South Station, is expected to be joined by life science, medical, and high-tech companies as time goes by.
Nobull which served as title sponsor of CrossFit Games and the PGA Tour, will occupy 86,000 of the 700,000 square feet at 135 Morrissey Blvd. Quincy-based contractor Lee Kennedy Co. is handling the buildout.
Studio Luz Architects of Roslindale designed the space, which includes workout and studio areas, locker rooms, a sauna, plunge pools, and a rock-climbing wall. A set-off track will be available throughout the office so that workers can do meetings on foot.
Nobull cofounders Michael Schaeffer and Marcus Wilson host a podcast titled “Behind the Horns,“ and the space also has room for a photography studio and a recording office.
Retail and outdoor space will follow in spring of 2023, after the interior headquarters is built out.
Nobull’s operations will be at the back of the building, where trains used deliver newsprint to the Globe .
“We are excited to begin the work on Nobull’s headquarters at the BEAT,” said Scott Giles, a vice president at Lee Kennedy, referring to an early name given the building as a nod to former Globe reporters. “Their innovation and creativity into their new office is a perfect fit for the diversification of LKCO’s Interiors/Special Projects sector. We are looking forward to providing an inventive space for Nobull to continue to expand and grow their business.”
The entire building, once it’s fully occupied, is expected to have 3,000 employees working inside, steps from the JFK/UMass MBTA Station.
The developers who converted the former Globe headquarters are eyeing an additional six-story building directly behind The Beat, with the hope of additional life science companies coming in.
